Skip to main content

ESTUDIOS CLINICOS, BASES GENETICAS Y BIOMARCADORES PRONOSTICOS EN ENFERMEDADES RARAS NEURODEGENERATIVAS

PI18/00147

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION CENTRO DE INVESTIGACION PRINCIPE FELIPE
Execution centre FUNDACION CENTRO DE INVESTIGACION PRINCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias

  • Martínez-Rubio, Dolores
  • Hinarejos, Isabel
  • Sancho, Paula
  • Gorría-Redondo, Nerea
  • Bernado-Fonz, Raquel
  • Tello, Cristina
  • Marco-Marín, Clara
  • Martí-Carrera, Itxaso
  • Martínez-González, María Jesús
  • García-Ribes, Ainhoa
  • Baviera-Muñoz, Raquel
  • Sastre-Bataller, Isabel
  • Martínez-Torres, Irene
  • Duat-Rodriguez, Anna
  • Janeiro, Patricia
  • Moreno, Esther
  • Pías-Peleteiro, Leticia
  • Gordo, Mar
  • O'Callaghan Ruiz-Gómez, Ángeles
  • Muñoz, Esteban
  • Martí, Maria Josep
  • Sánchez-Monteagudo, Ana
  • Fuster, Candela
  • Andrés-Bordería, Amparo
  • Pons, Roser Maria
  • Jesús-Maestre, Silvia
  • Mir, Pablo
  • Lupo, Vincenzo
  • Pérez-Dueñas, Belén
  • Darling, Alejandra
  • Aguilera-Albesa, Sergio
  • Espinós, Carmen
26 páginas, 4 figuras, 3 tablas, Our clinical series comprises 124 patients with movement disorders (MDs) and/or ataxia with cerebellar atrophy (CA), many of them showing signs of neurodegeneration with brain iron accumulation (NBIA). Ten NBIA genes are accepted, although isolated cases compatible with abnormal brain iron deposits are known. The patients were evaluated using standardised clinical assessments of ataxia and MDs. First, NBIA genes were analysed by Sanger sequencing and 59 patients achieved a diagnosis, including the detection of the founder mutation PANK2 p.T528M in Romani people. Then, we used a custom panel MovDisord and/or exome sequencing; 29 cases were solved with a great genetic heterogeneity (34 different mutations in 23 genes). Three patients presented brain iron deposits with Fe-sensitive MRI sequences and mutations in FBXO7, GLB1, and KIF1A, suggesting an NBIA-like phenotype. Eleven patients showed very early-onset ataxia and CA with cortical hyperintensities caused by mutations in ITPR1, KIF1A, SPTBN2, PLA2G6, PMPCA, and PRDX3. The novel variants were investigated by structural modelling, luciferase analysis, transcript/minigenes studies, or immunofluorescence assays. Our findings expand the phenotypes and the genetics of MDs and ataxias with early-onset CA and cortical hyperintensities and highlight that the abnormal brain iron accumulation or early cerebellar gliosis may resembling an NBIA phenotype., This work was supported by the Instituto de Salud Carlos III (ISCIII)—Subdirección General de Evaluación y Fomento de la Investigación within the framework of the National R + D+I Plan co-funded with European Regional Development Funds (ERDF) [Grants PI18/00147 and PI21/00103 to CE]; the Fundació La Marató TV3 [Grants 20143130 and 20143131 to BPD and CE]; and by the Generalitat Valenciana [Grant PROMETEO/2018/135 to CE]. Part of the equipment employed in this work was funded by Generalitat Valenciana and co-financed with ERDF (OP ERDF of Comunitat Valenciana 2014–2020). PS had an FPU-PhD fellowship funded by the Spanish Ministry of Education, Culture and Sport [FPU15/00964]. IH has a PFIS-PhD fellowship [FI19/00072]. ASM has a contract funded by the Spanish Foundation Per Amor a l’Art (FPAA), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Protein misfolding and clearance in the pathogenesis of a new infantile onset ataxia caused by mutations in PRDX3

  • Martínez-Rubio, Dolores
  • Rodríguez-Prieto, Ángela
  • Sancho, Paula
  • Navarro-González, Carmen
  • Gorría-Redondo, Nerea
  • Miquel-Leal, Javier
  • Marco-Marín, Clara
  • Jenkins, Alison
  • Soriano-Navarro, Mario
  • Hernández, Alberto
  • Pérez-Dueñas, Belén
  • Fazzari, Pietro
  • Aguilera-Albesa, Sergio
  • Espinós, Carmen
17 páginas, 8 figuras, Peroxiredoxin 3 (PRDX3) encodes a mitochondrial antioxidant protein, which is essential for the control of reactive oxygen species homeostasis. So far, PRDX3 mutations are involved in mild-to-moderate progressive juvenile onset cerebellar ataxia. We aimed to unravel the molecular bases underlying the disease in an infant suffering from cerebellar ataxia that started at 19 months old and presented severe cerebellar atrophy and peripheral neuropathy early in the course of disease. By whole exome sequencing, we identified a novel homozygous mutation, PRDX3 p.D163E, which impaired the mitochondrial ROS defense system. In mouse primary cortical neurons, the exogenous expression of PRDX3 p.D163E was reduced and triggered alterations in neurite morphology and in mitochondria. Mitochondrial computational parameters showed that p.D163E led to serious mitochondrial alterations. In transfected HeLa cells expressing the mutation, mitochondria accumulation was detected by correlative light electron microscopy. Mitochondrial morphology showed severe changes, including extremely damaged outer and inner membranes with a notable cristae disorganization. Moreover, spherical structures compatible with lipid droplets were identified, which can be associated with a generalized response to stress and can be involved in the removal of unfolded proteins. In the patient's fibroblasts, PRDX3 expression was nearly absent. The biochemical analysis suggested that the mutation p.D163E would result in an unstable structure tending to form aggregates that trigger unfolded protein responses via mitochondria and endoplasmic reticulum. Altogether, our findings broaden the clinical spectrum of the recently described PRDX3-associated neurodegeneration and provide new insight into the pathological mechanisms underlying this new form of cerebellar ataxia., The Instituto de Salud Carlos III (ISCIII)—Subdirección General de Evaluación y Fomento de la Investigación within the framework of the National R + D + I Plan cofunded with European Regional Development Funds (ERDF) (grants PI18/00147 and PI21/00103 to C.E.); the Spanish Ministry of Economy and Competitiveness (grant SAF2017-89020-R to P.F.); the Fundació La Marató TV3 (grants 20143130 and 20143131 to B.P.-D. and C.E.) and the Generalitat Valenciana (grant PROMETEO/2018/135 to C.E.). Part of the equipment employed in this work was funded by Generalitat Valenciana and co-financed with ERDF (OP ERDF of Comunitat Valenciana 2014-2020). P.F. and A.R.-P. are supported by the Spanish Ministry of Science and Innovation (grants RyC-2014-16410 to P.F. and PRE2018-083562 to A.R.-P.)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Expanding the β-III Spectrin-Associated Phenotypes toward Non-Progressive Congenital Ataxias with Neurodegeneration

  • Sancho, Paula
  • Andrés-Bordería, Amparo
  • Gorría-Redondo, Nerea
  • Llano, Katia
  • Martínez-Rubio, Dolores
  • Yoldi-Petri, María Eugenia
  • Perez Dueñas, Belen
Gen SPTBN2; Neurodegeneració; Atàxia congènita no progressiva, Gen SPTBN2; Neurodegeneración; Ataxia congénita no progresiva, SPTBN2 gene; Neurodegeneration; Non-progressive congenital ataxia, (1) Background: A non-progressive congenital ataxia (NPCA) phenotype caused by β-III spectrin (SPTBN2) mutations has emerged, mimicking spinocerebellar ataxia, autosomal recessive type 14 (SCAR14). The pattern of inheritance, however, resembles that of autosomal dominant classical spinocerebellar ataxia type 5 (SCA5). (2) Methods: In-depth phenotyping of two boys studied by a customized gene panel. Candidate variants were sought by structural modeling and protein expression. An extensive review of the literature was conducted in order to better characterize the SPTBN2-associated NPCA. (3) Results: Patients exhibited an NPCA with hypotonia, developmental delay, cerebellar syndrome, and cognitive deficits. Both probands presented with progressive global cerebellar volume loss in consecutive cerebral magnetic resonance imaging studies, characterized by decreasing midsagittal vermis relative diameter measurements. Cortical hyperintensities were observed on fluid-attenuated inversion recovery (FLAIR) images, suggesting a neurodegenerative process. Each patient carried a novel de novo SPTBN2 substitution: c.193A > G (p.K65E) or c.764A > G (p.D255G). Modeling and protein expression revealed that both mutations might be deleterious. (4) Conclusions: The reported findings contribute to a better understanding of the SPTBN2-associated phenotype. The mutations may preclude proper structural organization of the actin spectrin-based membrane skeleton, which, in turn, is responsible for the underlying disease mechanism., This work was supported by the Instituto de Salud Carlos III (ISCIII)—Subdirección General de Evaluación y Fomento de la Investigación within the framework of the National R+D+I Plan co-funded with ERDF funds [Grant PI18/00147], and by the Generalitat Valenciana [Grant PROMETEO/2018/135]. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014−2020). P.S. had an FPU-PhD fellowship funded by the Spanish Ministry of Education, Culture and Sport [FPU15/00964]. A.S.-M. has a contract funded by the Spanish Foundation Per Amor a l’Art (FPAA).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect

  • Correa Vela, Marta|||0000-0002-6255-5197
  • Lupo, Vincenzo|||0000-0002-3774-9854
  • Montpeyó Garcia-Moreno, Marta|||0000-0002-9241-1047
  • Sancho, Paula
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Darling, Alejandra
  • Jenkins, Alison
  • Fernández-Rodríguez, Sandra
  • Tello, Cristina
  • Ramírez-Jiménez, Laura
  • Pérez, Belén|||0000-0001-5801-1704
  • Sánchez Montáñez, Ángel
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Sobrido, María-Jesús
  • Martinez-Vicente, Marta|||0000-0001-7053-2625
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • Espinós, Carmen|||0000-0003-4435-1809
FBXO7 is implicated in the ubiquitin-proteasome system and parkin-mediated mitophagy. FBXO7defects cause a levodopa-responsive parkinsonian-pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368C.
Dipòsit Digital de Documents de la UAB
Publication

NR4A2 Mutations Can Cause Intellectual Disability and Language Impairment With Persistent Dystonia-Parkinsonism

  • Jesús, Silvia
  • Hinarejos, Isabel|||0000-0001-9548-4359
  • Carrillo, Fátima
  • Martínez-Rubio, Dolores
  • Macías-García, Daniel|||0000-0002-4822-1529
  • Sánchez-Monteagudo, Ana
  • Adarmes-Gómez, A.D.|||0000-0002-1337-9289
  • Lupo, Vincenzo|||0000-0002-3774-9854
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • Mir, Pablo|||0000-0003-1656-302X
  • Espinós, Carmen|||0000-0003-4435-1809
TheNR4A2/NURR1gene (MIM*601828) has recently been associated with autosomal-dominantearly-onset dystonia-parkinsonism with intellectual disability.1NR4A2codifies for a nuclear tran-scription factor and is expressed mainly in the substantia nigra, ventral tegmental area, and limbicareas.2To date, 14 different alterations inNR4A2have been described associated with variousclinical phenotypes, mainly with neurodevelopment disorders (table e-1, links.lww.com/NXG/A371). We describe here an interesting case suffering a persistent dystonia-parkinsonism syndrome(DPS) with motor tics, which expands the clinical phenotype ofNR4A2-associated DPS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Expanding the β-III Spectrin-Associated Phenotypes toward Non-Progressive Congenital Ataxias with Neurodegeneration

  • Sancho, Paula
  • Andrés-Bordería, Amparo
  • Gorría-Redondo, Nerea
  • Llano, Katia
  • Martínez-Rubio, Dolores
  • Yoldi-Petri, María Eugenia
  • Blumkin, Luba
  • Rodríguez de la Fuente, Pablo
  • Gil-Ortiz, Fernando
  • Fernández-Murga, Leonor
  • Sánchez-Monteagudo, Ana
  • Lupo, Vincenzo|||0000-0002-3774-9854
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • Espinós, Carmen|||0000-0003-4435-1809
  • Aguilera-Albesa, Sergio|||0000-0003-3540-1448
(1) Background: A non-progressive congenital ataxia (NPCA) phenotype caused by β-III spectrin (SPTBN2) mutations has emerged, mimicking spinocerebellar ataxia, autosomal recessive type 14 (SCAR14). The pattern of inheritance, however, resembles that of autosomal dominant classical spinocerebellar ataxia type 5 (SCA5). (2) Methods: In-depth phenotyping of two boys studied by a customized gene panel. Candidate variants were sought by structural modeling and protein expression. An extensive review of the literature was conducted in order to better characterize the SPTBN2 -associated NPCA. (3) Results: Patients exhibited an NPCA with hypotonia, developmental delay, cerebellar syndrome, and cognitive deficits. Both probands presented with progressive global cerebellar volume loss in consecutive cerebral magnetic resonance imaging studies, characterized by decreasing midsagittal vermis relative diameter measurements. Cortical hyperintensities were observed on fluid-attenuated inversion recovery (FLAIR) images, suggesting a neurodegenerative process. Each patient carried a novel de novo SPTBN2 substitution: c.193A.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Expanding the β-III Spectrin-Associated Phenotypes toward Non-Progressive Congenital Ataxias with Neurodegeneration

  • Sancho, Paula
  • Andrés-Bordería, Amparo
  • Gorría-Redondo, Nerea
  • Llano, Katia
  • Martínez-Rubio, Dolores
  • Yoldi-Petri, María Eugenia
  • Perez Dueñas, Belen
Gen SPTBN2; Neurodegeneració; Atàxia congènita no progressiva, Gen SPTBN2; Neurodegeneración; Ataxia congénita no progresiva, SPTBN2 gene; Neurodegeneration; Non-progressive congenital ataxia, (1) Background: A non-progressive congenital ataxia (NPCA) phenotype caused by β-III spectrin (SPTBN2) mutations has emerged, mimicking spinocerebellar ataxia, autosomal recessive type 14 (SCAR14). The pattern of inheritance, however, resembles that of autosomal dominant classical spinocerebellar ataxia type 5 (SCA5). (2) Methods: In-depth phenotyping of two boys studied by a customized gene panel. Candidate variants were sought by structural modeling and protein expression. An extensive review of the literature was conducted in order to better characterize the SPTBN2-associated NPCA. (3) Results: Patients exhibited an NPCA with hypotonia, developmental delay, cerebellar syndrome, and cognitive deficits. Both probands presented with progressive global cerebellar volume loss in consecutive cerebral magnetic resonance imaging studies, characterized by decreasing midsagittal vermis relative diameter measurements. Cortical hyperintensities were observed on fluid-attenuated inversion recovery (FLAIR) images, suggesting a neurodegenerative process. Each patient carried a novel de novo SPTBN2 substitution: c.193A > G (p.K65E) or c.764A > G (p.D255G). Modeling and protein expression revealed that both mutations might be deleterious. (4) Conclusions: The reported findings contribute to a better understanding of the SPTBN2-associated phenotype. The mutations may preclude proper structural organization of the actin spectrin-based membrane skeleton, which, in turn, is responsible for the underlying disease mechanism., This work was supported by the Instituto de Salud Carlos III (ISCIII)—Subdirección General de Evaluación y Fomento de la Investigación within the framework of the National R+D+I Plan co-funded with ERDF funds [Grant PI18/00147], and by the Generalitat Valenciana [Grant PROMETEO/2018/135]. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014−2020). P.S. had an FPU-PhD fellowship funded by the Spanish Ministry of Education, Culture and Sport [FPU15/00964]. A.S.-M. has a contract funded by the Spanish Foundation Per Amor a l’Art (FPAA).